Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-50
SponsorM.D. Anderson Cancer Center

About this trial

The goal of this research study is to learn about:

The effect of enrolling in the YOLC program on patient satisfaction with care provided,

The needs of patients younger than 50 with lung cancer and their family, and

The impact of participating in peer support networks on these patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age greater than 18 years and under 50 years

Histologic confirmation of NSCLC

Able to complete an English-language survey independently or with the assistance of a native-language interpreter

Pregnant women- may be enrolled due to age range of subjects. (Low risk)

Disqualifiers

Medical, psychiatric, cognitive, or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.

Individuals who are not yet adults (infants, children, teenagers)

Prisoners

Cognitively-impaired adults

Trial population

MD Anderson

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Survey

    Other intervention

    Participants will complete an intake survey and repeat surveys at the following time points: * Baseline * 3 months * 6 months * 9 months * 12 months * 18 months * 24 months * 36 months * 48 months * 60 months

Treatment groups

75 Participants
are divided into 1 treatment group
Group A: Assessment of Patients with Young-Onset Lung Cancer1 intervention

Trial outcomes

Primary outcomes

1

Participant satisfaction with care

Assessed via validated survey instruments (e.g., FACT-L, COST-FACIT). • Focus on detecting even small changes in survey responses over time (baseline, 3, 6, 9, 12 months, etc.).

Time frame
Through study completion; an average of 5 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.